New Research Coverage Highlights Innovative Industrial Properties, Attunity, TransAlta, Independence Holding, Sienna Biopharmaceuticals, and Majesco Consolidated Revenues, Company Growth, and Expectations for 2019

Globe Newswire 17-Apr-2019 8:50 AM

NEW YORK, April 17, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Innovative Industrial Properties, Inc. (NYSE:IIPR), Attunity Ltd. (NASDAQ:ATTU), TransAlta Corporation (NYSE:TAC), Independence Holding Company (NYSE:IHC), Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), and Majesco (NASDAQ:MJCO), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

IIPR DOWNLOAD: http://Capital-Review.com/register/?so=IIPR
ATTU DOWNLOAD: http://Capital-Review.com/register/?so=ATTU
TAC DOWNLOAD: http://Capital-Review.com/register/?so=TAC
IHC DOWNLOAD: http://Capital-Review.com/register/?so=IHC
SNNA DOWNLOAD: http://Capital-Review.com/register/?so=SNNA
MJCO DOWNLOAD: http://Capital-Review.com/register/?so=MJCO

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Capital Review, available for free download at the links above, examine Innovative Industrial Properties, Inc. (NYSE:IIPR), Attunity Ltd. (NASDAQ:ATTU), TransAlta Corporation (NYSE:TAC), Independence Holding Company (NYSE:IHC), Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), and Majesco (NASDAQ:MJCO) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

INNOVATIVE INDUSTRIAL PROPERTIES, INC. (IIPR) REPORT OVERVIEW

Innovative Industrial Properties' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Innovative Industrial Properties reported revenue of $4.78MM vs $2.28MM (up 109.60%) and analysts estimated basic earnings per share $0.26 vs $0.09 (up 188.89%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Innovative Industrial Properties reported revenue of $14.79MM vs $6.42MM (up 130.33%) and analysts estimated basic earnings per share $0.76 vs -$0.13. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.23. The estimated EPS forecast for the next fiscal year is $4.13 and is expected to report on March 11th, 2020.

To read the full Innovative Industrial Properties, Inc. (IIPR) report, download it here: http://Capital-Review.com/register/?so=IIPR

-----------------------------------------

ATTUNITY LTD. (ATTU) REPORT OVERVIEW

Attunity's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Attunity reported revenue of $25.98MM vs $18.28MM (up 42.17%) and analysts estimated basic earnings per share $0.11 vs -$0.08. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Attunity reported revenue of $86.25MM vs $62.10MM (up 38.89%) and analysts estimated basic earnings per share $0.28 vs -$0.39. Analysts expect earnings to be released on May 2nd, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.02. The estimated EPS forecast for the next fiscal year is $0.44 and is expected to report on January 30th, 2020.

To read the full Attunity Ltd. (ATTU) report, download it here: http://Capital-Review.com/register/?so=ATTU

-----------------------------------------

TRANSALTA CORPORATION (TAC) REPORT OVERVIEW

TransAlta's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, TransAlta reported revenue of $470.35MM vs $499.64MM (down 5.86%) and analysts estimated basic earnings per share -$0.34 vs -$0.39. For the twelve months ended December 31st, 2018 vs December 31st, 2017, TransAlta reported revenue of $1,735.10MM vs $1,779.62MM (down 2.50%) and analysts estimated basic earnings per share -$0.66 vs -$0.51. Analysts expect earnings to be released on May 14th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.18. The estimated EPS forecast for the next fiscal year is $0.09 and is expected to report on February 26th, 2020.

To read the full TransAlta Corporation (TAC) report, download it here: http://Capital-Review.com/register/?so=TAC

-----------------------------------------

INDEPENDENCE HOLDING COMPANY (IHC) REPORT OVERVIEW

Independence Holding's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Independence Holding reported revenue of $87.65MM vs $82.67MM (up 6.03%) and basic earnings per share $0.32 vs $1.14 (down 71.93%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Independence Holding reported revenue of $350.78MM vs $320.49MM (up 9.45%) and analysts estimated basic earnings per share $1.92 vs $2.67 (down 28.09%). Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019.

To read the full Independence Holding Company (IHC) report, download it here: http://Capital-Review.com/register/?so=IHC

-----------------------------------------

SIENNA BIOPHARMACEUTICALS, INC. (SNNA) REPORT OVERVIEW

Sienna Biopharmaceuticals' Recent Financial Performance

Analysts expect earnings to be released on May 13th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.85. The estimated EPS forecast for the next fiscal year is -$2.45 and is expected to report on March 12th, 2020.

To read the full Sienna Biopharmaceuticals, Inc. (SNNA) report, download it here: http://Capital-Review.com/register/?so=SNNA

-----------------------------------------

MAJESCO (MJCO) REPORT OVERVIEW

Majesco's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Majesco reported revenue of $35.40MM vs $31.77MM (up 11.43%) and analysts estimated basic earnings per share $0.05 vs -$0.08. For the twelve months ended March 31st, 2018 vs March 31st, 2017, Majesco reported revenue of $122.99MM vs $121.77MM (up 1.00%) and analysts estimated basic earnings per share -$0.14 vs -$0.02. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019.

To read the full Majesco (MJCO) report, download it here: http://Capital-Review.com/register/?so=MJCO

-----------------------------------------

ABOUT CAPITAL REVIEW

Capital Review is a nationally recognized publisher of financial analysis, research reports, and exclusive market reporting. Institutional investors, registered brokers, professional traders, and personal investment advisers rely on Capital Review to quantify public company valuations, discover opportunity across asset classes, stay informed about market-moving events, and read exclusive analysis of important material developments. With 14 offices worldwide, Capital Review staffs and manages certified and registered financial professionals, including Chartered Financial Analyst® (CFA®) designation holders and FINRA® BrokerCheck® certified individuals with current and valid CRD® number designations, to enable continuous coverage of topics relevant to its regular active reader base.

REGISTERED MEMBER STATUS

Capital Review's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Capital Review's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Capital Review have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Capital Review's Compliance department by Phone, at +1 (410) 280-7496, or by E-mail at compliance@Capital-Review.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Capital Review, Capital Review members, and/or Capital Review affiliates are not responsible for any gains or losses that result from the opinions expressed. Capital Review makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Capital Review has not been compensated for the publication of this press release by any of the above mentioned companies. Capital Review is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Morena Zambada, Media Department
Office: +1 (410) 280-7496
E-mail: media@Capital-Review.com 

© 2019 Capital Review. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Capital-Review.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Image for Press Release 798881

Image for Press Release 798881